A vldl response element in the promoter region of the human pai-1 gene implicated in the impaired fibrinolysis of hypertriglyceridaemia
Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity is a common finding in patients with coronary heart disease (CHD), particularly in young post-infarction patients with hypertriglyceridaemia, and is associated with recurrence of cardiovascular events. Both environmental and genetic...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1996
|